When it comes to mRNA, seeing is believing
We are moving into a new era of genomic medicines that will target cancer, viruses and disease by editing our DNA and RNA. But the path to developing these drugs is not yet clear because of the incredibly small-scale drug developers are working with — our cells — and the complexity of the activities within […]